The mechanisms involved in NK cells in ovarian cancer treatment, the current status of clinical applications, and new research strategies in the future are summarized to provide a reference for the development of research and clinical practice in this field.
Wei-Hong Long, Cai-Yun Zhang, Can Zhang et al.· InflammoPharmacology· 0 citations
The molecular mechanisms underlying NAT10-mediated RNA ac4C modification and protein acetylation, as well as their biological functions across physiological and pathological contexts, are systematically summarized, with the aim of facilitating its clinical translation.
Chengyu Zhang, Jin Lu, Lu Tang et al.· Cell Biology and Toxicology· 0 citations
It is suggested that TP53AIP1 may serve as a potential prognostic biomarker and tumor-suppressive candidate in breast cancer, with its effects at least partly associated with MAPK pathway attenuation.
Meihai Deng, Xueting Wu, J. Bai et al.· Discover Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.